Impact of pelvic MRI in routine clinical practice on staging of IB1–IIA2 cervical cancer
Authors Zhang W, Chen C, Liu P, Li W, Hao M, Zhao W, Lu A, Ni Y
Received 8 December 2018
Accepted for publication 26 March 2019
Published 26 April 2019 Volume 2019:11 Pages 3603—3609
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Ms Justinn Cochran
Peer reviewer comments 2
Editor who approved publication: Professor Lu-Zhe Sun
Weifeng Zhang,1 Chunlin Chen,1 Ping Liu,1 Weili Li,1 Min Hao,2 Weidong Zhao,3 Anwei Lu,4 Yan Ni5
1Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, People’s Republic of China; 2Department of Obstetrics and Gynecology, Shanxi Medical University Second Hospital, Taiyuan, People’s Republic of China; 3Department of Gynecological Oncology, Anhui Provincial Cancer Hospital, Hefei, People’s Republic of China; 4Department of Obstetrics and Gynecology, Guizhou Provincial Maternal and Child Health Care Hospital, Guiyang, People’s Republic of China; 5Department of Obstetrics and Gynecology, Yuncheng Municipal Central Hospital, Yuncheng Municipal Central Hospital, Yuncheng, People’s Republic of China
Purpose: To evaluate the impact of pelvic magnetic resonance imaging (MRI) on staging of IB1–IIA2 cervical cancer in routine clinical practice.
Patients and Methods: A total of 1,016 patients with IB1-IIA2 cervical cancer who underwent primary surgery and preoperative pelvic MRI between January 2009 and December 2015 were identified in a retrospective multicentre study. Data on clinical stage, MRI reports and surgicopathologic findings were extracted from medical records. The impact of MRI on clinical staging was evaluated by comparison before and after combination of MRI. Using surgicopathologic findings as the reference standard, the impact of pelvic MRI on the accuracy of clinical staging was evaluated. Furthermore, the impact on the accuracy of individual staging parameters such as maximal tumor diameter, vaginal involvement or parametrial infiltration were also evaluated.
Results: After combination of pelvic MRI, clinical stage remained unchanged in 59.7%, upstaged in 17.2%, and downstaged in 23.0% of the patients. The overall accuracy of clinical staging increased from 61.0% to 81.4% in our study (P<0.05). As for individual staging parameters, the area under the curve (AUC) for maximal tumor diameter increased from 0.58 to 0.81 (P<0.05). However, the AUC for vaginal involvement decreased from 0.61 to 0.57 (P>0.05). The AUC for parametrial infiltration was also suboptimal (AUC=0.56, P<0.05).
Conclusion: In routine clinical practice, MRI could increase the overall accuracy of clinical staging in IB1–IIA2 cervical cancer. For staging parameters, it only significantly increased the accuracy of maximal tumor diameter.
Keywords: cervical cancer, staging, magnetic resonance imaging, MRI, accuracy, routine clinical practice, surgery
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]